Search

A median of 3 surgeons were involved throughout the patients' care cycle, 120 (69.0%) patients had different consenting surgeons v. POS, and 100 (57.5%) patients first met their POS at time of surgery. Results Excluding patients with multiple revisions and those without follow-up data, 48 patients were included in the analysis: 33 patients (69%) underwent conversion to LRGYB for insufficient weight loss/weight regain (group 1) and 15 patients (31%) underwent conversion for other reasons (group 2). Incidence, timing and outcomes of venous thromboembolism in patients undergoing surgery f... Background Abdominal surgery and chemotherapy are risk factors for venous thromboembolism (VTE) in patients with cancer, but their contribution in patients with esophagogastric cancer is unclear. Six recommendations were approved: 1) limit routine blood work to a maximum of 3 consecutive days; 2) no postoperative blood work for uncomplicated appendectomy patients; 3) no postoperative blood work for uncomplicated cholecystectomy patients; 4) order a single draw of lipase as the primary diagnostic marker of pancreatitis; 5) no routine investigations for choledocholithiasis and gallstone pancreatitis patients after duct clearance when booked for same-admission cholecystectomy; and 6) no routine investigations for adhesive small bowel obstruction patients who are tolerating oral intake. The rationale for dCRT varied as 6 patients had disease considered to be unresectable, 5 patients were originally considered to be medically inoperable, 4 patients had a preference for nonsurgical management initially, and 1 patient pursued dCRT owing to uncertainty of surgical options because of the COVID-19 pandemic. [Extracted from the article]